Oramed Pharmaceuticals Inc.
ORMP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Market Cap | $98,805 | $93,128 | $469,142 | $560,271 |
| - Cash | $54,420 | $9,055 | $40,464 | $77,245 |
| + Debt | $372 | $51,622 | $894 | $533 |
| Enterprise Value | $44,757 | $135,695 | $429,572 | $483,559 |
| Revenue | $0 | $1,340 | $2,703 | $2,703 |
| % Growth | -100% | -50.4% | 0% | – |
| Gross Profit | -$193 | $1,340 | $2,703 | $2,703 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | -$14,874 | $7,321 | -$36,976 | -$25,039 |
| % Margin | – | 546.3% | -1,368% | -926.3% |
| Net Income | -$19,103 | $5,525 | -$37,764 | -$22,238 |
| % Margin | – | 412.3% | -1,397.1% | -822.7% |
| EPS Diluted | -0.47 | 0.14 | -0.97 | -0.78 |
| % Growth | -435.7% | 114.4% | -24.4% | – |
| Operating Cash Flow | -$8,412 | -$10,295 | -$27,918 | -$21,181 |
| Capital Expenditures | -$18 | -$254 | -$496 | -$375 |
| Free Cash Flow | -$8,430 | -$10,549 | -$28,414 | -$21,556 |